![Alan Auerbach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Auerbach
Algemeen Directeur bij
PUMA BIOTECHNOLOGY, INC.
Vermogen: 66 M $ op 31-08-2026
Profiel
Alan H.
Auerbach was the founder of Cougar Biotechnology, Inc., founded in 2003, where the titles held included President, Chief Executive Officer & Director from 2003 to 2009.
Mr. Auerbach is the founder of Puma Biotechnology, Inc., founded in 2010, holding the titles of Chairman, President & Chief Executive Officer since 2010.
Former jobs include Chairman, President & Chief Executive Officer at Innovative Acquisitions Corp.; Independent Director at Radius Health, Inc. from 2011 to 2017; Vice President & Senior Research Analyst at Diagnostic Products Corp.
in 2011; Vice President & Senior Research Analyst at Wells Fargo Securities (Old) in 2003; and Vice President & Research Analyst at Seidler Cos., Inc. from 1997 to 1998.
Education includes undergraduate studies at Boston University and graduate studies at the University of Southern California.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 14,07% | 06-07-2026 | 7.261.671 ( 14,07% ) | 66 M $ | 31-08-2026 |
Actieve functies van Alan Auerbach
| Bedrijven | Functie | Begin |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Algemeen Directeur | 15-09-2010 |
Eerdere bekende functies van Alan Auerbach
| Bedrijven | Functie | Einde |
|---|---|---|
| RADIUS HEALTH, INC. | Directeur/Bestuurslid | 29-12-2017 |
Innovative Acquisitions Corp.
 Innovative Acquisitions Corp. Financial ConglomeratesFinance Provides investment services | Voorzitter | 09-12-2011 |
Cougar Biotechnology, Inc. /Old/
 Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Oprichter | 13-07-2009 |
Wells Fargo Securities (Old)
 Wells Fargo Securities (Old) Investment Banks/BrokersFinance Provides securities brokerage services | Analyst-Equity | 01-04-2003 |
Seidler Cos., Inc.
 Seidler Cos., Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-05-1998 |
Opleiding van Alan Auerbach
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
64
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Diagnostic Products Corp.
 Diagnostic Products Corp. Medical SpecialtiesHealth Technology Manufactures test and measurement equipment | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Provides investment services | Finance |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wells Fargo Securities (Old)
Wells Fargo Securities (Old) Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Seidler Cos., Inc.
Seidler Cos., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
